Advertisement
Screener

Evolent Health, Inc. (EVH) Overview

Evolent Health, Inc. (EVH) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.25; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.24; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -3.84; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.24; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.06$2.59$3.26$4.11$5.17$6.502025-11-062026-11-06$2.06$3.76$6.87$12.53$22.86$41.732021-11-082026-11-06$2.06$3.76$6.87$12.53$22.86$41.732016-11-072026-11-06$2.06$3.76$6.87$12.53$22.86$41.732015-06-052026-11-06$2.06$3.76$6.87$12.53$22.86$41.732015-06-052026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$4.58
Previous close
$3.52
Change
$1.06
Change (%)
29.97%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

EVH
-12.00%
S&P 500
(m)

1 year

EVH
-59.86%
S&P 500
(m)

3 years

EVH
-87.07%
S&P 500
(m)

5 years

EVH
-87.84%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.25

-3.92-2.96-1.99-1.02-0.0630 Jun 2025: estimate (m); actual -0.4430 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.2430 Sept 2025(m)31 Dec 2025: estimate (m); actual -3.8431 Dec 2025(m)31 Mar 2026: estimate (m); actual -0.2431 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.2530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.25(m)(m)
1 Jan 202631 Mar 2026(m)-0.24(m)(m)
1 Oct 202531 Dec 2025(m)-3.84(m)(m)
1 Jul 202530 Sept 2025(m)-0.24(m)(m)
1 Apr 202530 Jun 2025(m)-0.44(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -5.07

-5.15-3.87-2.58-1.30-0.0231 Dec 2021: estimate (m); actual -0.4431 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.2031 Dec 2022(m)31 Dec 2023: estimate (m); actual -1.2831 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.8131 Dec 2024(m)31 Dec 2025: estimate (m); actual -5.0731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-5.07(m)(m)
1 Jan 202431 Dec 2024(m)-0.81(m)(m)
1 Jan 202331 Dec 2023(m)-1.28(m)(m)
1 Jan 202231 Dec 2022(m)-0.20(m)(m)
1 Jan 202131 Dec 2021(m)-0.44(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 652.52M ■ Earnings -28.36M — Profit margin -4.35%

-558.93M-92.6%-111.85M-62.8%335.24M-33.1%782.32M-3.3%30 Sept 2025: revenue 479.53M; earnings -20.86M; profit margin -4.35%30 Sept 202531 Dec 2025: revenue 468.72M; earnings -429.13M; profit margin -91.55%31 Dec 202531 Mar 2026: revenue 496.25M; earnings -26.63M; profit margin -5.37%31 Mar 202630 Jun 2026: revenue 652.52M; earnings -28.36M; profit margin -4.35%30 Jun 2026

31 Dec 2025 ■ Revenue 1.88B ■ Earnings -0.58B — Profit margin -30.88%

-0.96B-31.9%0.34B-21.4%1.64B-10.9%2.93B-0.4%31 Dec 2022: revenue 1.35B; earnings -0.02B; profit margin -1.42%31 Dec 202231 Dec 2023: revenue 1.96B; earnings -0.14B; profit margin -7.25%31 Dec 202331 Dec 2024: revenue 2.55B; earnings -0.09B; profit margin -3.66%31 Dec 202431 Dec 2025: revenue 1.88B; earnings -0.58B; profit margin -30.88%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$4.58(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$4.58High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning EVH

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-549.88M
Profit margin
-26.22%
Return on assets · 12 month
-24.81%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.42M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-7.37%*
Total return · month
-23.48%*
Total return · quarter
-38.99%*
Total return · half year
59.28%*
Total return · year to date
-12.00%*
Total return · 1 year
-59.86%*
Total return · 3 years
-87.07%*
Total return · 5 years
-87.84%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.10B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Evolent Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1628908
Industry (SIC)
8741 Services-Management Services
Country of operation
United States
Business address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, Virginia, 22209, United States
Fiscal year end
1231
Phone
571-389-6000

Similar stocks

Stock NameCountryMarket CapPE Ratio
FRANKLIN COVEY CO (FC)United States$0.195B123.76
GARTNER INC (IT)United States$11.326B11.20